RAS testing for colorectal cancer patients is reliable in European laboratories that pass external quality assessment
Sign Up to like & getrecommendations! Published in 2017 at "Virchows Archiv"
DOI: 10.1007/s00428-017-2291-z
Abstract: Wild-type status of KRAS and the NRAS gene (exon 2, 3, and 4) in the tumor should be determined before treatment of metastatic colorectal cancer (mCRC) patients with EGFR-targeting agents. There is a large variation… read more here.
Keywords: ras testing; colorectal cancer; quality assessment; european laboratories ... See more keywords